Case number 1:21-cv-01032
Merz Pharmaceuticals, LLC et al v. MSN Pharmaceuticals Inc. > Documents
| Date Field | Doc. No. | Description (Pages) |
|---|---|---|
| Sep 22, 2021 | 11 | Order (2) Docket Text: SO ORDERED Granting [10] Joint Stipulation and Proposed Order of Dismissal Without Prejudice (***Civil Case Terminated). Signed by Judge Richard G. Andrews on 9/22/2021. (nms) |
| Sep 22, 2021 | 12 | Main Document (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,638,552; 7,816,396. (Attachments: # (1) Order)(nms) |
| Sep 22, 2021 | 12 | Order (2) |
| Sep 21, 2021 | 10 | Stipulation of Dismissal (2) Docket Text: STIPULATION of Dismissal Without Prejudice, by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Silver, Daniel) Modified on 9/22/2021 (nms). |
| Jul 29, 2021 | N/A | SO ORDERED (0) Docket Text: SO ORDERED, re [7] STIPULATION and Proposed Order to Extend Time (*Reset Answer Deadlines: MSN Pharmaceuticals Inc. answer due 10/25/2021). Signed by Judge Richard G. Andrews on 7/29/2021. (nms) |
| Jul 29, 2021 | 7 | Stipulation to EXTEND Time (2) Docket Text: STIPULATION TO EXTEND TIME Defendant's Deadline to Answer, Move or Otherwise Respond to the Complaint to October 25, 2021 - filed by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Silver, Daniel) |
| Jul 29, 2021 | 8 | Stipulation (3) Docket Text: STIPULATION Regarding Venue and Personal Jurisdiction by Merz North America, Inc., Merz Pharmaceuticals, LLC. (Silver, Daniel) |
| Jul 29, 2021 | 9 | Order (3) Docket Text: SO ORDERED Granting [8] Stipulation Regarding Venue and Personal Jurisdiction. Signed by Judge Richard G. Andrews on 7/29/2021. (nms) |
| Jul 21, 2021 | N/A | Case Assigned/Reassigned (0) Docket Text: Case Assigned to Judge Richard G. Andrews. Please include the initials of the Judge (RGA) after the case number on all documents filed. (rjb) |
| Jul 15, 2021 | 1 | Main Document (10) Docket Text: COMPLAINT for PATENT INFRINGEMENT filed against MSN Pharmaceuticals Inc. - Magistrate Consent Notice to Pltf. ( Filing fee $ 402, receipt number ADEDC-3658208.) - filed by Merz Pharmaceuticals, LLC, Merz North America, Inc. (Attachments: # (1) Exhibit A-B, # (2) Civil Cover Sheet)(smg) |
| Jul 15, 2021 | 1 | Exhibit A-B (24) |
| Jul 15, 2021 | 1 | Civil Cover Sheet (1) |
| Jul 15, 2021 | 2 | Magistrate Consent Forms (3) Docket Text: Notice, Consent and Referral forms re: U.S. Magistrate Judge jurisdiction. (smg) |
| Jul 15, 2021 | 3 | ANDA Form (1) Docket Text: Supplemental information for patent cases involving an Abbreviated New Drug Application (ANDA) - Date Patentee(s) Received Notice: June 9, 2021. Date of Expiration of Patent: August 20, 2023.Thirty Month Stay Deadline: 12/9/2023. (smg) |
| Jul 15, 2021 | 4 | Patent/Trademark Report to Commissioner (1) Docket Text: Report to the Commissioner of Patents and Trademarks for Patent/Trademark Number(s) 7,638,552 ; 7,816,396. (smg) |
| Jul 15, 2021 | 5 | Disclosure Statement (2) Docket Text: Disclosure Statement pursuant to Rule 7.1: identifying Corporate Parent Merz Pharmaceuticals GmbH, Corporate Parent Merz Pharmaceuticals GmbH & Co. KGaA, Corporate Parent Merz, Incorporated for Merz North America, Inc., Merz Pharmaceuticals, LLC filed by Merz North America, Inc., Merz Pharmaceuticals, LLC. (smg) |
| Jul 15, 2021 | 6 | Summons Issued - Electronic (2) Docket Text: Summonses Issued as to MSN Pharmaceuticals Inc.(please complete the top portion of the form and print out for use/service). (smg) |
| Jul 15, 2021 | 1 | Complaint* (1) |
